4//SEC Filing
Slichenmyer William 4
Accession 0001181431-12-039761
CIK 0001325879other
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 4:21 PM ET
Size
8.3 KB
Accession
0001181431-12-039761
Insider Transaction Report
Form 4
Slichenmyer William
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2012-07-03$9.64/sh+1,000$9,640→ 24,693 total - Sale
Common Stock
2012-07-03$13.00/sh−1,000$13,000→ 23,693 total - Exercise/Conversion
Stock Option (right to buy)
2012-07-03−1,000→ 110,500 totalExercise: $9.64Exp: 2019-10-08→ Common Stock (1,000 underlying)
Footnotes (2)
- [F1]The exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2010.
- [F2]The option vested as to 25% of the shares on September 14, 2010 and thereafter vests in equal monthly installments as to the remaining shares through September 14, 2013.
Documents
Issuer
AVEO PHARMACEUTICALS INC
CIK 0001325879
Entity typeother
Related Parties
1- filerCIK 0001486428
Filing Metadata
- Form type
- 4
- Filed
- Jul 4, 8:00 PM ET
- Accepted
- Jul 5, 4:21 PM ET
- Size
- 8.3 KB